drugset / Trial / NCT04170088

Comparison of Efficacy of Tranexamic Acid Mesotherapy Versus 0.9% Normal Saline for Melasma

NCT04170088

Phase 2/3 Completed 30 enrolled Jinnah Postgraduate Medical Centre
RandomizedSingle-groupDouble-blindTreatment

Summary

It is a randomized controlled trial in which investigators determine the efficacy of tranexamic acid (TA) by mesotherapy in comparison to normal saline on participants having Melasma.

Timeline

Start
2018-09-01
Primary completion
2019-05-01
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 4 mg/ml Other

Indications